Trials / Completed
CompletedNCT03955120
Validation of the Dayzz Digital Sleep Training App in Insomnia and Sleep Apnea
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Dayzz Live Well Ltd. · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The prevalence of sleep disorders has achieved epidemic proportions in Western countries. Despite this, assessment and treatment of sleep disorders remains infrequent, unattainable, and often costly. Dayzz is aware of the need for easily accessible, user-friendly, and affordable treatment strategies for known sleep conditions. This research proposes a randomized controlled outcome study aimed to validate a, digitized, cost-effective mobile app which assesses and manages insomnia and CPAP adherence in persons with sleep apnea. The app's sleep training protocols recommend life-style and behavioral changes and tracks these changes with the aim of improving sleep and well-being. In this study, the dayzz app digital treatment protocol will be compared to the standard treatment for these sleep conditions by a sleep professional.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dayzz mobile sleep training | 1. The dayzz digital sleep program provides each user with relevant educational materials (depending on their sleep condition), sleep tracking, and sleep or health-related tasks or challenges pertaining to their sleep or sleep difficulties. 2. Each app user is matched with a "sleep trainer" who will communicate with them via a "chat" option within the dayzz app and who will support the participants with any sleep training issues or technical aspects of all app for the duration of the treatment program. 3. Participants receive a wrist-worn device for monitoring sleep and activity patterns, a Fitbit fitness tracker (www.fitbit.com), to be worn for the duration of the study. |
| OTHER | Treatment as usual | Standard medical care for specific sleep condition |
Timeline
- Start date
- 2019-01-29
- Primary completion
- 2020-12-30
- Completion
- 2020-12-30
- First posted
- 2019-05-17
- Last updated
- 2021-08-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03955120. Inclusion in this directory is not an endorsement.